Group 1 - The company held its first extraordinary general meeting of shareholders on September 1, 2025, with no rejected proposals [2][3] - The meeting was conducted in accordance with the Company Law and the company's articles of association, combining on-site and online voting [3][4] - All directors and supervisors attended the meeting, ensuring a quorum was present [4] Group 2 - The following proposals were approved at the meeting: the 2025 Restricted Stock Incentive Plan, its management measures, and the authorization for the board to handle related matters [5][6][7] - The voting results indicated that proposals requiring special resolutions received over two-thirds approval, while ordinary resolutions received more than half [6][7] Group 3 - The company conducted a self-examination regarding insider trading related to the 2025 Restricted Stock Incentive Plan, confirming no insider trading occurred during the review period [9][10] - Three individuals were found to have trading records, but their actions were based on publicly available information, not insider information [10][11] Group 4 - The company announced the first grant of restricted stock on September 1, 2025, at a price of 22.06 yuan per share, granting a total of 2.64 million shares to 278 eligible participants [14][16][18] - The total number of shares granted represents approximately 2.2913% of the company's total share capital at the time of the plan's announcement [16][23] Group 5 - The company confirmed that the conditions for granting the restricted stock were met, with no disqualifying circumstances for either the company or the participants [19][21] - The board and supervisory committee verified the eligibility of the participants and the compliance of the granting process with relevant regulations [22][40] Group 6 - The company utilized the Black-Scholes model to calculate the fair value of the restricted stock, with parameters including a stock price of 29.23 yuan per share and a historical volatility of approximately 19.995% [30][31] - The estimated impact of the stock incentive plan on the company's financial performance will be assessed in accordance with accounting standards [31][32]

Core Viewpoint - The company has completed the repurchase and cancellation of 103,994 restricted stocks, which accounts for 0.02% of the total share capital before the repurchase, due to the departure of three incentive targets [2][9]. Summary by Sections Repurchase and Cancellation Details - The repurchase price for the restricted stocks is set at 4.458 yuan per share, with a total cost of 46.36 thousand yuan, funded by the company's own resources [2][13]. - After the cancellation, the company's total share capital will decrease from 504,968,262 shares to 504,864,268 shares [2][9]. Approval Process - The company held board and supervisory meetings on April 25, 2025, to approve the repurchase and cancellation of the restricted stocks, which was subsequently ratified by the shareholders [3][8]. - The incentive plan has undergone various approvals since December 30, 2022, including receiving consent from the State-owned Assets Supervision and Administration Commission [4][5]. Reasons for Repurchase - The repurchase was necessitated by the termination of employment for two individuals due to uncontrollable job transfers and one individual leaving for personal reasons, making them ineligible for the incentive program [9][10]. Financial Adjustments - The repurchase price was adjusted due to previous equity distributions, resulting in a final repurchase price of 4.458 yuan per share [12][13]. - The company has confirmed that the repurchase will not impact its operational performance or the diligence of its management team [15].

1、本次回购注销2023年限制性股票数量为1,656股，占公司2023年限制性股票激励计划首次授予登记完 成但尚未解除限售的限制性股票数量1,141,927股的0.15%；本次回购注销2024年限制性股票数量为2,100 股，占公司2024年限制性股票激励计划首次授予登记完成但尚未解除限售的限制性股票数量1,560,580股 的0.13%。以上共回购注销3,756股，占本次回购注销前公司总股本226,890,028股的0.0017%，共向2名原 限制性股票激励对象支付回购注销款90,969.69元。 2、截至本公告披露日，上述限制性股票已在中国证券登记结算有限责任公司深圳分公司完成注销手 续。 3、本次限制性股票回购注销符合法律、行政法规、部门规章、规范性文件、《公司章程》《2023年限 制性股票激励计划（草案）》《2024年限制性股票激励计划（草案）》等的相关规定。 公司于2025年7月28日，召开2025年第二次临时股东大会，审议通过了《关于回购注销2023年限制性股 票激励计划部分限制性股票的议案》《关于回购注销2024年限制性股票激励计划部分限制性股票的议 案》，同意公司根据《2023年限制性股票激励 ...

Core Viewpoint - The company announced the cancellation of unvested restricted stock from the 2023 incentive plan due to certain recipients no longer qualifying for the incentive program [1][4]. Summary by Sections Approval Procedures - The company has completed the necessary approval procedures for the 2023 restricted stock incentive plan, including independent opinions from directors [1][2]. Specifics of Canceled Restricted Stock - A total of 1.725 million shares of restricted stock were canceled due to 16 recipients leaving the company and one recipient failing to meet performance criteria [4][5]. Impact on the Company - The cancellation of the unvested restricted stock will not significantly impact the company's financial status or operational results, nor will it affect the stability of the core team or the continuation of the incentive plan [4][5]. Opinions from the Compensation and Assessment Committee - The committee agreed with the cancellation, stating it aligns with the relevant regulations and does not harm shareholder interests [4][5]. Supervisory Board Opinion - The supervisory board confirmed that the cancellation complies with the incentive plan's regulations and unanimously agreed to the cancellation of the 1.725 million shares [4][5].

Core Viewpoint - The company has announced the achievement of the vesting conditions for the second vesting period of its 2023 restricted stock incentive plan, allowing 231 eligible participants to receive a total of 15,380,000 shares of restricted stock [1][19][22] Summary by Sections Stock Incentive Plan Overview - The 2023 restricted stock incentive plan was approved in multiple meetings, with the main content including the issuance of restricted stock to eligible participants [1][2] - The total number of shares to be granted is 32,000,000, with a grant price of 3.37 yuan per share [6][10] Vesting Conditions - The first vesting period requires a net profit of no less than 300 million yuan for 2023, while the second vesting period requires a cumulative net profit of no less than 610 million yuan for 2023 and 2024 [2][4] - The vesting conditions have been met, allowing the eligible participants to receive the shares [14][17] Performance Assessment - The performance assessment for individual participants is based on internal performance evaluation criteria, with results categorized into six levels from "Excellent" to "Unqualified" [3][4] - If an individual's performance is rated as "Needs Improvement" or "Unqualified," they will forfeit their right to the shares [4][17] Adjustments and Changes - The number of eligible participants has been adjusted from 244 to 232 due to the disqualification of certain individuals [12][19] - The grant price of the restricted stock has been adjusted from 3.37 yuan to 2.87 yuan due to annual equity distribution [13][19] Financial Impact - The company will account for the fair value of the restricted stock granted and will adjust the expected number of shares based on performance metrics and participant changes [22][23] - The source of the shares includes both repurchased shares from the secondary market and newly issued shares to participants [23]

Summary of Key Points Core Viewpoint The announcement details that the first vesting period of the 2023 Restricted Stock Incentive Plan of Beijing Hekang New Energy Technology Co., Ltd. has met the vesting conditions, allowing the company to proceed with the stock vesting for eligible participants. Group 1: Incentive Plan Overview - The incentive plan involves the issuance of 33.5 million restricted stocks, accounting for 3.01% of the company's total share capital of 1,112.613857 billion shares [2][6] - The initial grant of restricted stocks is set at 27.6 million shares, representing 17.61% of the total restricted stocks under the plan [2][6] - The grant price for the restricted stocks is 5.16 yuan per share [2][6] Group 2: Vesting Conditions and Performance Targets - The first vesting period is defined as starting from 16 months after the grant date and lasting until the last trading day of the 28th month, with a vesting ratio of 50% [2][3] - Performance targets for the first vesting period require a revenue increase of no less than 10% compared to 2022 and a net profit increase of no less than 6% [3][10] - The second and third vesting periods have progressively higher performance targets, with revenue increases of 205% and 345% respectively by 2025 and 2026 [3][10] Group 3: Approval and Compliance - The board of directors and the supervisory board have approved the vesting conditions and the list of eligible participants, confirming compliance with relevant laws and regulations [4][12] - The company has established a performance evaluation system for individual participants, with grades ranging from S to D, affecting the vesting ratio [4][11] - The announcement confirms that the vesting conditions have been met, allowing for the vesting of 2,075,000 shares to 36 eligible participants [11][12] Group 4: Impact on Financials and Share Structure - The vesting of 2,075,000 shares will increase the total share capital from 1,125,709,857 shares, but will not significantly impact the company's financial status or operational results [14][15] - The company will account for the stock compensation in accordance with relevant accounting standards, ensuring that the vesting does not adversely affect shareholder interests [14][15]

Group 1 - The company held its 23rd meeting of the second board of directors on August 26, 2025, with all 9 directors present, and the meeting was chaired by Chairman Zhen Lixin [1][2] - The board approved the draft of the 2025 Restricted Stock Incentive Plan, which aligns with relevant laws and regulations, and is expected to benefit the company's sustainable development [2][5] - The board also approved the management measures for the implementation of the 2025 Restricted Stock Incentive Plan, ensuring its smooth execution and alignment with the company's governance structure [2][3] Group 2 - The board proposed to authorize the board to handle matters related to the 2025 Restricted Stock Incentive Plan, including determining eligibility, adjusting stock quantities, and managing the vesting process [5][6] - The board agreed to convene the second extraordinary general meeting of shareholders on September 17, 2025, to discuss the approved proposals [6][7]

Core Viewpoint - The legal opinion letter from Fangda Partners addresses the adjustments to the stock incentive plan of Shanghai Aopumai Biotechnology Co., Ltd., including the adjustment of grant prices, the cancellation of unvested shares, and the confirmation of vesting conditions for certain stock grants [1][6][19]. Summary by Sections Legal Framework - The legal opinion is based on various Chinese laws and regulations, including the Company Law, Securities Law, and specific guidelines from the China Securities Regulatory Commission and the Shanghai Stock Exchange [2][3]. Price Adjustment - The stock grant price for the incentive plan was adjusted from 25.00 CNY per share to 24.14 CNY per share, following the calculation of dividends distributed to shareholders [10][11][19]. Cancellation of Shares - A total of 35,000 shares were confirmed to be canceled due to the departure of two incentive recipients who no longer qualified for the incentive program [12][13][19]. Vesting Conditions - The vesting conditions for the first grant's second vesting period and the reserved grant's first vesting period have been met, confirming a total of 297,800 shares eligible for vesting, with 264,000 shares from the first grant and 33,800 shares from the reserved grant [18][19].

证券代码：688293 证券简称：奥浦迈 公告编号：2025-074 通过了《关于确认作废 <公司 ensp="ensp" 年限制性股票激励计划="年限制性股票激励计划"> 部分已授 予尚未归属 上海奥浦迈生物科技股份有限公司 关于确认作废公司 2023 年限制性股票激励计划部分 已授予尚未归属的限制性股票的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 上海奥浦迈生物科技股份有限公司（以下简称"公司"或"奥浦迈"）于 2025 年 9 月 1 日召开第二届董事会第十二次会议、第二届监事会第十一次会议，审议 的限制性股票的议案》，现将相关事项公告如下： 一、本次限制性股票授予已履行的决策程序和信息披露情况 《关于 <公司 ensp="ensp" 年限制性股票激励计划="年限制性股票激励计划" 草案="草案"> 及其摘要的 议案》 《关于 <公> 司 2023 年限制性股票激励计划实施考核管理办法>的议案》《关于提请股东大会 授权董事会办理公司股权激励计划相关事宜的议案》等议案，公司独立董事就本 激励计划相关议案发表了 ...

Core Viewpoint - The company has approved the reserve grant list for the 2024 restricted stock incentive plan, ensuring compliance with relevant regulations and internal procedures [1][2]. Group 1: Public Disclosure and Verification - The public disclosure included the names and positions of the reserve grant incentive objects [2]. - The public disclosure period was from August 22, 2025, to August 31, 2025, lasting a total of 10 days [2]. - The disclosure was conducted internally, and feedback was collected through designated phone lines, email, or in-person communication, with no objections received during the public disclosure period [2][3]. Group 2: Review and Compliance - The Compensation and Assessment Committee of the Board verified the eligibility of the reserve grant incentive objects against the criteria set forth in the management regulations and the draft incentive plan [2][3]. - The committee confirmed that all individuals listed in the reserve grant incentive objects met the necessary qualifications and conditions as per the relevant laws and regulations [3].